Investors seeking exposure to smaller U.S. companies frequently weigh active management against rules-based, factor-driven strategies, and few pairings illustrate that trade-off as cleanly as FESM and FSMD. Both funds sit in the small-cap segment of the equity market and serve a similar investor goal: capturing the growth and diversification potential of smaller listed businesses. Yet their construction could hardly differ more. FESM relies on Fidelity's portfolio managers and quantitative models to tilt an active portfolio within the Russell 2000 universe, while FSMD passively tracks a multifactor index. This comparison clarifies their structural differences, sector exposure, and relative positioning for today's market environment. I also checked this using Tickeron’s AI Screener to see how the two line up against peers.
FESM is an actively managed fund that normally invests at least 80% of its assets in common stocks within the Russell 2000 Index, a widely followed benchmark of the U.S. small-cap market. Rather than replicating that index, Fidelity's managers use quantitative models to tilt holdings toward names scoring well on growth, momentum, and other factors, giving the fund an "enhanced" active character. The fund holds roughly 700 to 900 securities, and its top positions have recently included A-Mark Precious Metals, Bloom Energy, Credo Technology, Guardant Health, Fabrinet, ACM Research, StoneX Group, and Kulicke & Soffa.
Sector allocation leans toward healthcare, technology, and financial services, with industrials and consumer cyclical following. The fund carries a net expense ratio of 0.28% and a turnover that reflects its active rebalancing. With a beta above 1.2 in recent cycles, FESM tends to move more sharply than the broader market, a structural feature of its small-cap, momentum-oriented positioning.
FSMD seeks to track the Fidelity Small-Mid Multifactor Index, a rules-based benchmark designed to reflect U.S. small- and mid-capitalization companies with attractive valuations, higher quality profiles, positive momentum signals, and lower volatility than the broader market. The fund normally invests at least 80% of assets in index constituents, holding roughly 600 securities spanning a wider capitalization band that extends into mid-cap territory.
Top holdings have recently included AngloGold Ashanti, Ciena, Comfort Systems USA, Tapestry, United Therapeutics, EMCOR Group, Flex, Pure Storage, Tenet Healthcare, and nVent Electric. Sector exposure is dominated by industrials, technology, and financial services, with healthcare and consumer cyclical also notable. FSMD charges a competitive 0.15% net expense ratio and operates with a beta near 1.0, reflecting its multifactor, lower-volatility construction and broad diversification across the small- and mid-cap spectrum. From what I see, the lower beta stands out when comparing risk profiles.
Both ETFs are heavily shaped by the small-cap segment's sensitivity to interest-rate expectations, credit conditions, and domestic economic growth. Smaller companies typically carry higher financing costs and thinner balance-sheet buffers, making them more reactive to Federal Reserve policy shifts and banking-sector liquidity than large-cap peers. In recent market cycles, small caps have also benefited from investor rotation away from concentrated mega-cap technology leadership toward more cyclically balanced, domestically oriented businesses.
The industrials, financials, and healthcare exposures common to both funds tie their performance to manufacturing activity, regional bank health, and healthcare spending trends. Semiconductor and artificial-intelligence demand has additionally lifted select small-cap technology and industrial names held by both portfolios. Key risks include a growth slowdown, tighter credit, and lingering volatility in rates, all of which tend to amplify small-cap drawdowns. I’m watching this closely as rate expectations evolve.
Across recent market cycles, FESM has tended to deliver stronger absolute returns when small-cap momentum and risk appetite are elevated, reflecting its active tilts and higher beta. Its concentration in higher-momentum technology and healthcare names can amplify both gains and losses. FSMD, by contrast, has generally exhibited a smoother return path, with its multifactor emphasis on value, quality, and lower volatility providing more defensive relative positioning during risk-off periods.
The two funds also differ in cost and liquidity structure. FSMD's 0.15% expense ratio and broad, low-concentration holdings favor long-horizon, cost-conscious investors, while FESM's active approach carries a higher fee and greater single-position concentration. In broad terms, FESM offers higher upside potential with higher risk, whereas FSMD presents a more balanced, factor-diversified profile better suited to investors prioritizing risk-adjusted consistency.
In my view, tools like Tickeron’s AI Screener help cut through the noise when comparing ETFs like these. It lets me quickly filter on factors such as volatility, sector exposure, and performance metrics to confirm how FESM and FSMD stack up against similar funds. This approach has become a regular part of how I evaluate positioning and risk before making allocation decisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
FSMD saw its Momentum Indicator move above the 0 level on October 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In 86 of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FSMD's RSI Indicator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Moving Average Convergence Divergence (MACD) for FSMD just turned positive on October 02, 2026. Looking at past instances where FSMD's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.
FSMD moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for FSMD crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +0.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where FSMD advanced for three days, in 246 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 225 of 279 cases where FSMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 55 of 70 cases where FSMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FSMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
FSMD broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category SmallBlend